Catalyst Event
Biogen Inc (BIIB) · Other
From Akros U.S. Large Cap 500 Index (AUL500)
5/24/2026, 12:00:00 AM
U.S. FDA decision on the supplemental application for LEQEMBI IQLIK on 2026-05-24; price impact is estimated to be ≥10% as a major drug catalyst, expected.
Korean Translation
미국 FDA의 2026년 5월 24일 레켐비 이클릭 피하주사 제형 승인 결정; 주요 신약 촉매제로서 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host an Investor Day on June 9, 2026; a >=5% price impact is estimated as the company provides strategic updates scheduled.
6/9/2026, 12:00:00 AM
Chipotle Mexican Grill Inc (CMG) · Other
Shareholders approved a 50-for-1 stock split at the annual meeting on June 6, 2026. This major corporate action is expected to have a high price impact as it confirms the historic split scheduled.
6/6/2026, 12:00:00 AM
Hewlett Packard Enterprise Co (HPE) · Earnings Release
Q2 2026 earnings release is scheduled.
6/2/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
First quarter fiscal year 2027 earnings results are scheduled to be released on May 29, 2026. Market impact is estimated at >1% as earnings releases typically drive volatility scheduled.
5/29/2026, 12:00:00 AM
Analog Devices Inc (ADI) · Earnings Release
Analog Devices is expected to release its fiscal second quarter 2026 financial results around late May. The date is estimated based on previous reporting schedules and is scheduled.
5/28/2026, 12:00:00 AM
Costco Wholesale Corp (COST) · Earnings Release
Third quarter fiscal 2026 earnings release, estimated to have a moderate impact on the stock price upon release, scheduled.
5/28/2026, 12:00:00 AM